Indian pharmaceutical company, Zydus Cadila, announced that it has received an approval to market Empagliflozin & Metformin Hydrochloride tablets.

The share purchase and shareholders’ agreement (SPSA) with regards to this deal was implemented amongst the company, CLP and ATL on July 3, 2019.

In the coming week, Nifty has strong support around the levels of 9,300-9,400 and on the upside, 9970-10,000 is a strong resistance. Stocks in news: Coal India, Tata Motors, Kalpataru Power Transmission, Laurus Labs, MOIL.

Welcome to the first trading session of the week as well as the first trading session for the month of May. Pessimism is seen greeting Dalal Street on the first trading session as there is a new risk to growth in the form of revival of the trade war as hinted by US.

Sequencing risk often affect your investments during retirement. In this article we would look at its impact on your retirement corpus.

New Fund Offers (NFOs) that are open for subscription.

Air-conditioning & commercial refrigeration products maker, Blue Star Ltd, announced that the company is planning to raise Rs 300 crore through the issuance of non-convertible debentures to meet its capital expenditure as well as other expenses after the lockdown.

Indian hydropower generation company, NHPC Ltd, informed that it is planning to borrow Rs 2,000 crore by way of raising debt.

Cadila announced that the board of directors of the company at a meeting held on April 30, 2020, have signed an agreement for the sale of the shares that it holds of Windlas Healthcare Private Limited (WHPL).

After the rapid spread of Coronavirus, the gold prices were seen zooming as this safe-haven asset was preferred during the time when the economies globally were busy implementing lockdowns.